Humana Inc. $HUM Stake Raised by Quantitative Investment Management LLC

Key Points

• Quantitative Investment Management LLC significantly increased its stake in Humana Inc. by 4,009.6% during the 1st quarter, now holding 56,301 shares worth approximately $14.9 million.
• Institutional investors currently own 92.38% of Humana's stock, indicating strong institutional support for the company.
• Humana recently declared a quarterly dividend of $0.885 per share, contributing to an annualized dividend yield of 1.2%.

Quantitative Investment Management LLC boosted its position in Humana Inc. (NYSE:HUM - Free Report) by 4,009.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 56,301 shares of the insurance provider's stock after buying an additional 54,931 shares during the quarter. Humana makes up about 1.4% of Quantitative Investment Management LLC's investment portfolio, making the stock its 12th biggest holding. Quantitative Investment Management LLC's holdings in Humana were worth $14,897,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of HUM. Vanguard Group Inc. grew its position in shares of Humana by 8.9% in the 1st quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider's stock worth $3,697,222,000 after acquiring an additional 1,143,662 shares in the last quarter. Dodge & Cox lifted its stake in Humana by 5.5% during the first quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider's stock worth $2,845,830,000 after purchasing an additional 557,175 shares during the last quarter. Pzena Investment Management LLC boosted its holdings in Humana by 6.1% in the first quarter. Pzena Investment Management LLC now owns 3,828,923 shares of the insurance provider's stock worth $1,013,133,000 after purchasing an additional 219,541 shares during the period. Davis Selected Advisers boosted its holdings in Humana by 3.3% in the first quarter. Davis Selected Advisers now owns 2,331,343 shares of the insurance provider's stock worth $616,873,000 after purchasing an additional 74,434 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC increased its stake in Humana by 1.6% during the first quarter. Hotchkis & Wiley Capital Management LLC now owns 1,236,936 shares of the insurance provider's stock valued at $327,293,000 after purchasing an additional 19,613 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on HUM. Raymond James Financial upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price target on the stock in a research report on Thursday, May 1st. Robert W. Baird dropped their price objective on shares of Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a research note on Friday, July 25th. Cantor Fitzgerald restated a "neutral" rating and issued a $290.00 target price on shares of Humana in a research note on Thursday, May 1st. Bank of America lowered their target price on Humana from $320.00 to $260.00 and set a "neutral" rating for the company in a report on Tuesday, June 17th. Finally, Piper Sandler dropped their price target on Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a research report on Thursday, July 31st. Seven equities research analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. Based on data from MarketBeat, Humana has an average rating of "Hold" and an average price target of $283.29.

Humana Stock Performance

Shares of NYSE:HUM traded up $0.73 on Thursday, hitting $297.99. The company's stock had a trading volume of 997,473 shares, compared to its average volume of 1,708,251. The company has a market capitalization of $35.84 billion, a price-to-earnings ratio of 22.87, a price-to-earnings-growth ratio of 1.76 and a beta of 0.44. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $382.72. The stock's 50-day moving average is $252.05 and its two-hundred day moving average is $254.08.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The company had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. Humana's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. On average, equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a $0.885 dividend. The ex-dividend date is Friday, September 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.2%. Humana's dividend payout ratio (DPR) is 27.17%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.